ENT Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic ENT Devices, Surgical ENT Devices, Nasal Splints), End-user (ENT Clinics, Home Use), By Region and Forecast (2026 2031)

The Global ENT Devices Market is expected to witness a single-digit growth rate by 2031. The key factors driving the ENT devices market's growth are growing number of endoscopic examinations due to rise in laryngeal and pharyngeal cancers, growing number of endoscopic sinus surgery (ESS) procedures, increasing aging population, growing prominence of artificial intelligence (AI) in ENT and skull base procedures, and technological advancements in ENT devices.

ENT Devices are used in the identification, therapy, or surgical treatment of any ear, nose and throat disorders. These devices help in correcting problems related to hearing, smell, snoring, or speaking. Some of the ENT devices available in the market are endoscopes, hearing aids, hearing screening instruments, hearing implants, ear tubes, voice prosthesis devices, surgical devices, powered surgical tools, image-guided surgery systems, balloon dilation devices which are used in sinus, CO2 lasers, among others.

Promising Prospects of Artificial Intelligence (AI) in the Global ENT Devices Market

The advent of AI is projected to revolutionize the evolution of image-guided ENT and skull base procedures and favorably impact the diagnosis of laryngeal cancers. Citing the potential prospects of AI in the ENT devices market, all key players are incessantly striving to launch innovative products in the global ENT devices market. For instance:

In September 2021, Acclarent launched its first-ever AI-powered ENT technology in the U.S., designed to simplify surgical planning and provide real-time feedback during ENT navigation procedures.

Similarly, AI is poised to make giant strides in the field of Otolaryngology. The Netherlands based company WSK Medical is optimistic that by the end of the year 2023, European otolaryngologists may be using artificial intelligence (AI) to diagnose laryngeal cancer. The company has developed a platform - Zeno AI - that gives ENT-surgeons a real-time AI analysis of early laryngeal cancer detection that can be utilised during an endoscopic examination (laryngoscopy). Zeno AI considerably reduces time to analyse complex medical data and assists in diagnosing laryngeal cancer faster. The product is not commercialized yet but it is already in use in two European academic medical centers and in proving helpful in identifying laryngeal lesions.

Technological Innovations and Advancements Triggers the ENT Devices Market's Growth

The global ENT devices market has witnessed a significant number of technological advancements and innovations over the years. The technological advancements in ENT devices market is expected to spur its demand in the upcoming years. For instance:

In August 2022, Preceptis Medical secured U.S. FDA clearance for expanded indications for use for the Hummingbird Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures. The system was previously cleared in children 6-24 months, this new labeling allows in-office procedures in all children six months and older.

In April 2022, Atmos MedizinTechnik GmbH & Co. KG launched the next generation of endoscopes for ENT and swallowing diagnostics - the Atmos Scope. The flexible HD video nasopharyngolaryngoscope sets new standards with its high image resolution and, via its USB interface, enables mobile use with portable devices.

Competitive Landscape Analysis

Some of the established players operating in the global ENT devices market are Karl Storz, Medtronic, Stryker, Smith+Nephew, Olympus, Entermed, Acclarent (Part of Johnson & Johnson MedTech), Fujifilm, Aesculap (B Braun), Preceptis Medical, Eakin Surgical, FENTEXmedical GmbH, Sheffmed, PENTAX Medical, Atmos MedizinTechnik GmbH & Co. KG, Collin SAS, Adept Medical, among others.

Organic and Inorganic Growth Strategies Adopted by the Key Market Players to Establish Their Foothold in the Global ENT Devices Market

Leading players operating in this market are adopting organic and inorganic growth strategies such as launching new products, acquiring related firms, and entering into collaborations to garner a higher market share. For instance,

In September 2023, Olympus Corporation launched the Vathin E-SteriScope- single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures. The E-SteriScope single-use flexible video rhinolaryngoscope is manufactured by Hunan Vathin Medical Instrument and distributed exclusively by Olympus. It is available for sale in the U.S., and its availability in Europe, Middle East and Africa is anticipated later this year.

In July 2022, Zsquare, a leading developer of high-performance, single-use endoscopes, received Food and Drug Administration 510K clearance to market its first product, the Zsquare ENT-Flex- Rhinolaryngoscope. It is indicated for use in diagnostic ENT procedures by way of the nose and throat and is the only scalable platform capable of transmitting high-resolution images in flexible, single-use endoscopes.

In May 2022, Medtronic completed the acquisition of Intersect ENT, a global ear, nose, and throat (ENT) medical technology leader. The acquisition expands the company's comprehensive ENT portfolio with innovative products used in sinus procedures.

The global ENT devices market is expected to gain a consistent momentum in the upcoming years due to growing number of ear tube procedures (tympanostomy) among kids, rising expectations for sinusitis treatments in outpatient and office settings and aggressive organic and inorganic growth strategies followed by the leading market players.

Market Scope